{
  "id": "8c53a751d1081f91",
  "title": "INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives",
  "description": "20260127T150000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/01/27/tmt-newswire/globenewswire/inmune-bio-inc-issues-shareholder-letter-reviewing-2025-milestones-and-outlining-2026-strategic-initiatives/2266239",
  "published_at": "20260127T150000Z",
  "fetched_at": "2026-01-28T00:24:25.269376+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/01/27/tmt-newswire/globenewswire/inmune-bio-inc-issues-shareholder-letter-reviewing-2025-milestones-and-outlining-2026-strategic-initiatives/2266239",
    "url_mobile": "https://www.manilatimes.net/2026/01/27/tmt-newswire/globenewswire/inmune-bio-inc-issues-shareholder-letter-reviewing-2025-milestones-and-outlining-2026-strategic-initiatives/2266239/amp",
    "title": "INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives",
    "seendate": "20260127T150000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/01/27/914618.png",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}